Sarcoma Cases Rise in Álava, Sparking Calls for Increased Awareness and Early Detection
A slight but concerning increase in sarcoma diagnoses in the Álava province of Spain is prompting health officials to emphasize the importance of early detection and specialized treatment for these rare, yet aggressive, cancers. While representing just 1% of malignant tumors in adults, sarcomas disproportionately impact children and adolescents, making vigilance crucial. July 13th is observed annually as World Sarcoma Cancer Day, dedicated to raising visibility and support for those affected by these diseases impacting connective tissues – bones, muscles, fat, and blood vessels.
The Challenge of Sarcoma Diagnosis and Treatment
Sarcomas present a significant challenge for both patients and healthcare professionals due to their complexity and diversity. Effective management requires prompt diagnosis and specialized treatment protocols. “The diagnostic process requires a multidisciplinary approach, from primary care to Osakidetza Tumor Committees,” highlighting the collaborative effort needed to navigate these complex cases. Recent advancements are focusing on personalized treatments, targeted therapies, and innovative surgical techniques, including the use of proton therapy now available in Euskadi.
Rising Incidence in Álava and Euskadi
Data from Álava reveals a steady increase in the number of tumors classified within the sarcoma group. In 2022, 268 cases were diagnosed, rising to 297 by 2025. This trend is mirrored across the broader Euskadi region, with cases increasing from 1,986 in 2022 to 2,185 in 2025. Bizkaia currently reports the highest number of cases, followed by Gipuzkoa and Álava. The majority of diagnoses are concentrated within the 46-75 age group, though a significant number of cases also occur in children under 18 and individuals over 75. The gender distribution is nearly equal, with 147 men and 150 women diagnosed in Álava last year.
Understanding Sarcomas: Types and Symptoms
Sarcomas are malignant tumors originating in the bones or soft tissues. “They can appear anywhere in the organism, unlike carcinomas, which affect organs,” explained a medical professional. In younger patients, osteosarcoma and Ewing sarcoma – linked to bone growth – are most common. Adults are more likely to develop soft tissue sarcomas, which can occur in limbs, organs like the uterus or abdomen, and other areas of the body.
Early detection is paramount, given the complexity of diagnosis. A key recommendation from Osakidetza professionals is to seek medical attention for any persistent pain without a clear cause, or for the appearance of a growing lump, even if it’s not painful. “A simple radiography can be decisive,” they advise.
Osakidetza’s Role in Patient Care
Osakidetza, the Basque Country’s public health service, plays a vital role in the comprehensive management of sarcoma patients. Specialized units at the University Hospital of Cruces and the Donostia University Hospital provide dedicated care and monitoring. According to a senior official, “Sarcoma is a less frequent type of cancer compared to others such as breast, lung, prostate or colon.” However, the service recognizes the unique challenges these cancers present.
It’s important to note that bone cancer diagnoses in adults are often misattributed, with many cases actually being metastasis from other cancers, leading to delayed and potentially less effective treatment. Children under 18 with sarcoma are treated at the Donostia University Hospital Centers and Cruces University Hospital, with diagnosis and treatment evaluated by the Autonomous Committee of Pediatric Oncology. Patients may also be included in open clinical trials, and complex surgical cases are referred to specialized centers and reference units (CSUR).
The Impact on Children and Families
The treatment of childhood cancer presents unique clinical and emotional hurdles. “Childhood cancer affects all aspects of the child’s life and his family,” emphasizing the need for holistic care. Osakidetza provides comprehensive support encompassing medical, psychological, and social needs, ensuring continued access to education through home tutoring and hospital-based programs. Family conciliation is also prioritized, recognizing the long-term functional and side effects that can accompany treatment.
A medical professional concluded, “I want to take advantage of these lines to raise awareness about this rare and complex management tumor, consult the aforementioned symptoms because the early diagnosis is essential in the management of these tumors.” Early intervention remains the most powerful tool in improving outcomes for those affected by sarcoma.
